在美国和欧盟,Tezspire已获批准作为一次性预充式注射器和自动注射器供自我给药。 参考来源:‘Tezspire met both co-primary endpoints in the Phase III WAYPOINT trial in patients with chronic rhinosinusitis with nasal ...
To ensure a smooth transition to ABI DataStream, ABI Research offers full and seamless onboarding support. Our team will work with you to set up APIs, allowing effortless access to ABI Research ...